Selected research
Market Structure
Global Piracetam API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Piracetam API market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Piracetam API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Piracetam API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Piracetam API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Piracetam API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Piracetam API include Shanghai Modern Hasen, Jiangxi Yuehua Pharmaceutical, Jiangxi Yiyou Pharmaceutical, NORTHEAST Pharmaceutical, Polpharma, Microsin SRL and Lavybens Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Piracetam API market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Piracetam API and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Piracetam API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Piracetam API market size, projected growth trends, production technologies, key applications, and end-use industries.
Piracetam API Segment by Company
Shanghai Modern Hasen
Jiangxi Yuehua Pharmaceutical
Jiangxi Yiyou Pharmaceutical
NORTHEAST Pharmaceutical
Polpharma
Microsin SRL
Lavybens Pharma
Piracetam API Segment by Type
Putiry>98%
Putiry>99%
Piracetam API Segment by Application
Injection Drugs
Oral Drugs
Piracetam API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Piracetam API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Piracetam API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Piracetam API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Piracetam API market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Piracetam API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Piracetam API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Piracetam API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Putiry>98%
- Putiry>99%
Applications
- Injection Drugs
- Oral Drugs
Companies covered
- Shanghai Modern Hasen
- Jiangxi Yuehua Pharmaceutical
- Jiangxi Yiyou Pharmaceutical
- NORTHEAST Pharmaceutical
- Polpharma
- Microsin SRL
- Lavybens Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Piracetam API Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Piracetam API Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Piracetam API Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Piracetam API Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Piracetam API Market Dynamics
- 2.1 Piracetam API Industry Trends
- 2.2 Piracetam API Industry Drivers
- 2.3 Piracetam API Industry Opportunities and Challenges
- 2.4 Piracetam API Industry Restraints
3 Piracetam API Market by Manufacturers
- 3.1 Global Piracetam API Revenue by Manufacturers (2021-2026)
- 3.2 Global Piracetam API Sales by Manufacturers (2021-2026)
- 3.3 Global Piracetam API Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Piracetam API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Piracetam API Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Piracetam API Manufacturers, Product Type & Application
- 3.7 Global Piracetam API Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Piracetam API Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Piracetam API Players Market Share by Revenue in 2025
- 3.8.3 2025 Piracetam API Tier 1, Tier 2, and Tier 3
4 Piracetam API Market by Type
- 4.1 Piracetam API Type Introduction
- 4.1.1 Putiry>98%
- 4.1.2 Putiry>99%
- 4.2 Global Piracetam API Sales by Type
- 4.2.1 Global Piracetam API Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Piracetam API Sales by Type (2021-2032)
- 4.2.3 Global Piracetam API Sales Market Share by Type (2021-2032)
- 4.3 Global Piracetam API Revenue by Type
- 4.3.1 Global Piracetam API Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Piracetam API Revenue by Type (2021-2032)
- 4.3.3 Global Piracetam API Revenue Market Share by Type (2021-2032)
5 Piracetam API Market by Application
- 5.1 Piracetam API Application Introduction
- 5.1.1 Injection Drugs
- 5.1.2 Oral Drugs
- 5.2 Global Piracetam API Sales by Application
- 5.2.1 Global Piracetam API Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Piracetam API Sales by Application (2021-2032)
- 5.2.3 Global Piracetam API Sales Market Share by Application (2021-2032)
- 5.3 Global Piracetam API Revenue by Application
- 5.3.1 Global Piracetam API Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Piracetam API Revenue by Application (2021-2032)
- 5.3.3 Global Piracetam API Revenue Market Share by Application (2021-2032)
6 Global Piracetam API Sales by Region
- 6.1 Global Piracetam API Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Piracetam API Sales by Region (2021-2032)
- 6.2.1 Global Piracetam API Sales by Region (2021-2026)
- 6.2.2 Global Piracetam API Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Piracetam API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Piracetam API Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Piracetam API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Piracetam API Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Piracetam API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Piracetam API Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Piracetam API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Piracetam API Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Piracetam API Revenue by Region
- 7.1 Global Piracetam API Revenue by Region
- 7.1.1 Global Piracetam API Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Piracetam API Revenue by Region (2021-2026)
- 7.1.3 Global Piracetam API Revenue by Region (2027-2032)
- 7.1.4 Global Piracetam API Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Piracetam API Revenue (2021-2032)
- 7.2.2 North America Piracetam API Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Piracetam API Revenue (2021-2032)
- 7.3.2 Europe Piracetam API Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Piracetam API Revenue (2021-2032)
- 7.4.2 Asia-Pacific Piracetam API Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Piracetam API Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Piracetam API Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Shanghai Modern Hasen
- 8.1.1 Shanghai Modern Hasen Company Information
- 8.1.2 Shanghai Modern Hasen Business Overview
- 8.1.3 Shanghai Modern Hasen Piracetam API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Shanghai Modern Hasen Piracetam API Product Portfolio
- 8.1.5 Shanghai Modern Hasen Recent Developments
- 8.2 Jiangxi Yuehua Pharmaceutical
- 8.2.1 Jiangxi Yuehua Pharmaceutical Company Information
- 8.2.2 Jiangxi Yuehua Pharmaceutical Business Overview
- 8.2.3 Jiangxi Yuehua Pharmaceutical Piracetam API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Jiangxi Yuehua Pharmaceutical Piracetam API Product Portfolio
- 8.2.5 Jiangxi Yuehua Pharmaceutical Recent Developments
- 8.3 Jiangxi Yiyou Pharmaceutical
- 8.3.1 Jiangxi Yiyou Pharmaceutical Company Information
- 8.3.2 Jiangxi Yiyou Pharmaceutical Business Overview
- 8.3.3 Jiangxi Yiyou Pharmaceutical Piracetam API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Jiangxi Yiyou Pharmaceutical Piracetam API Product Portfolio
- 8.3.5 Jiangxi Yiyou Pharmaceutical Recent Developments
- 8.4 NORTHEAST Pharmaceutical
- 8.4.1 NORTHEAST Pharmaceutical Company Information
- 8.4.2 NORTHEAST Pharmaceutical Business Overview
- 8.4.3 NORTHEAST Pharmaceutical Piracetam API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 NORTHEAST Pharmaceutical Piracetam API Product Portfolio
- 8.4.5 NORTHEAST Pharmaceutical Recent Developments
- 8.5 Polpharma
- 8.5.1 Polpharma Company Information
- 8.5.2 Polpharma Business Overview
- 8.5.3 Polpharma Piracetam API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Polpharma Piracetam API Product Portfolio
- 8.5.5 Polpharma Recent Developments
- 8.6 Microsin SRL
- 8.6.1 Microsin SRL Company Information
- 8.6.2 Microsin SRL Business Overview
- 8.6.3 Microsin SRL Piracetam API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Microsin SRL Piracetam API Product Portfolio
- 8.6.5 Microsin SRL Recent Developments
- 8.7 Lavybens Pharma
- 8.7.1 Lavybens Pharma Company Information
- 8.7.2 Lavybens Pharma Business Overview
- 8.7.3 Lavybens Pharma Piracetam API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Lavybens Pharma Piracetam API Product Portfolio
- 8.7.5 Lavybens Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Piracetam API Value Chain Analysis
- 9.1.1 Piracetam API Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Piracetam API Production Mode & Process
- 9.2 Piracetam API Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Piracetam API Distributors
- 9.2.3 Piracetam API Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst